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DIETARY APPROACHES TO STOP HYPERTENSION DIETARY PATTERN, 
PHYSICAL ACTIVITY, AND RISK OF ATHEROSCLEROTIC 
CARDIOVASCULAR DISEASE  
ERIC D. GLANZ  
 
ABSTRACT 
Background: Atherosclerotic cardiovascular (ASCVD) disease is the leading cause of 
death in the United States. Longstanding poor nutrition habits and lack of exercise 
contribute to chronic inflammation and promote the development ASCVD. In clinical 
trials, the Dietary Approaches to Stop Hypertension (DASH) eating pattern, a diet rich in 
nutrients with anti-inflammatory and antioxidant properties, has been shown to reduce the 
risk of hypertension. Its role in overall cardiovascular (CV) health, both alone and in 
combination with an active lifestyle, is less clear. 
 
Objectives: The primary goal of this study is to examine the relationships between the 
DASH eating pattern, physical activity, the development of incident cardiovascular 
disease (CVD). Specifically, we will evaluate the independent and combined effects of 
DASH and moderate to vigorous physical activity (MVPA) on cardiovascular event risk 
among men and women in the Framingham Heart Study Offspring (FOS) cohort.  
 
Methods: The DASH score was derived from two sets of three-day dietary records 
gathered during examination visits 3 and 5 in the prospective FOS cohort. Activity was 
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self-reported and used to generate a composite score for MVPA. Scores were constructed 
for each individual by multiplying the number of hours spent during each day in 
sedentary, light, moderate, and vigorous activity by a standard weights reflecting the 
intensity of that activity. Subjects included 2503 individuals (1137 men and 1366 
women), aged 30 years and older. Individuals were free of type II diabetes mellitus 
(T2DM), cancer, and cardiovascular disease at baseline. The DASH score was 
categorized according to adherence to the eating pattern, first as low, moderate, or high 
adherence and then dichotomized (DASH score <4.45 vs. ≥4.45). The MVPA score was 
classified into quintiles and also dichotomized (MVPA score <6.1 vs. ≥6.1). The 
dichotomous DASH and MVPA scores were then cross-classified and each subject was 
assigned to one of the following categories: (1) low DASH score / low activity (referent), 
(2) low DASH / high activity, (3) high DASH / low activity, and (4) high DASH / high 
activity. Follow-up started at exam 5 and continued through the ninth examination cycle 
in 2014. Cox proportional-hazard regression models were used to estimate hazard ratios 
(HRs) and 95% confidence intervals (CIs) for all subjects and for men and women 
independently, adjusting for confounding by age, BMI, cigarettes smoked per day, and 
grams per day of alcohol consumed. Factors found not to confound the effects of DASH 
and MVPA on CV risk were excluded from final models.  
 
Results: During a median follow-up of approximately 20 years, 286 and 177 incident CVD 
cases were documented among men and women, respectively. Women in the highest 
DASH adherence category had approximately 28% lower total CVD risk than women in 
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the lowest adherence group (HR, 0.72; 95% CI: 0.48-1.10). Effects in men were weaker. 
Women in the highest quintile of MVPA score had approximately 44% lower risk of CVD 
than women in the lowest quintile (HR, 0.66; 95% (0.40-1.10). Overall, CVD risk was 26% 
lower (HR: 0.74 (95% CI: 0.55-0.99) for those in quintile 5 vs. quintile 1. Women in the 
High DASH/High MVPA category had a 43% lower total CVD risk than women in the Low 
DASH/Low MVPA group (HighDASH/HighMVPA: HR, 0.57; 95% (0.36-0.90)). These 
associations were generally stronger in women than men.  
 
Conclusions: In this prospective cohort study, active individuals with higher adherence 
to DASH was associated with a lower atherosclerotic CVD risk compared to those with 
lower activity and DASH adherence. The beneficial effects of diet in particular were 
stronger among women than men.  
 
Keywords: cardiovascular disease risk, Dietary Approaches to Stop Hypertension, 
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Globally, cardiovascular disease (CVD) is the leading cause of death1. Atherosclerosis is 
a burdensome and common cardiovascular condition resulting from chronic inflammation 
to the arterial vasculature 2. To highlight recent reports, atherosclerosis is a global disease 
affecting more than 200 million individuals and 12 million Americans, incidence has 
increased by nearly a quarter in the last decade 2. This disease affects 20% of primary 
care patients with approximately one-third of all patients aged 70 or older contributing to 
and  negatively influencing life and longevity 3. Atherosclerosis in the peripheral arteries 
is a slow developing chronic condition resulting in narrowing of the arteries 4. The 
severity of the symptoms associated with atherosclerosis is defined by the degree of 
narrowing of the vasculature. Thus, many patients may remain asymptomatic throughout 
their life making it under diagnosed condition 2,4.   
 
Atherosclerosis is a multifactorial disease and the identification of causal factors and their 
treatments may decrease additional increased morbidity associated with atherosclerosis 
among patients with CVD. 1 found that incident symptomatic atherosclerosis had a 
significant association with an increased risk of subsequent CV events, death, myocardial 
infarction (MI) and the need for coronary revascularization. Risk factors for the 
development of chronic inflammatory damage to the arterial vasculature of the limbs 3,5 
include age, gender, Type II diabetes mellitus, glycemic control, cardiac disease severity, 
hypertension, hypercholesterolemia, and inflammation 6. Almost one half of all excess 




The link between atherosclerosis and disease 
Atherosclerosis is a chronic condition in which arteries become stiff through the build-up 
of plaque 8. Atherosclerotic plaque includes lipids, cholesterol, and calcium inside of 
arteries which obstructs the blood vessels’ ability to carry oxygen rich blood to the heart, 
extremities, and the brain 9. Various CVD risk factors (smoking, diabetes, dyslipidemia) 
may be the initial factor leading to endothelial cell injury 10.  
 
Upon endothelial injury or disruption, lipoprotein particles can deposit in endothelial 
lesions and subsequently oxidized by free radicals or oxidation enzymes via a number of 
mechanisms. These mechanisms may involve dendritic cells, macrophages, cytokines or 
surface proteins on stressed cells. This accumulation of oxidized lipoprotein particles 
triggers activation of cytotoxic lymphocytes which play critical roles in inflammatory 
diseases and in controlling infections and diseases 11. Pro-inflammatory cytokines are 
secreted as well as cytotoxins that promote inflammation and the development of 
atherosclerotic lesions 10. The atheroma then forms a fibrous cap, made up of 
macrophages and smooth muscle cells. This leads to vulnerable fatty lesions, and the 
intima of the endothelium continues to thicken as the fatty streak evolves and calcifies 9. 
These lesions are strongly implicated in myocardial infarction (MI) and stroke 10. 
Unstable plaque with deep injury and real defect or a gap in the fibrous cap that has 
separated its lipid rich atheroma core from blood flow can rupture. Plaque rupture is 
associated with 76% of all fatal heart attacks caused by thrombosis worldwide 12. 
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Atherosclerotic Disease Progression 
 
Arterial stiffness predicts the onset of hypertension, a key risk factor for cardiovascular 
diseases 1,2. Currently, hypertension affects nearly half of adults globally and its prevalence 
is increasing dramatically among all age groups 13. Several strategies including lifestyle 
modifications and medication use have been suggested for the management of 
hypertension.  
 
Age-related arterial dysfunction is characterized by thickening of the artery wall, a 
reduction in endothelial and autonomic function, and increased arterial stiffness 14. Arterial 
stiffness is one of the earliest detectable manifestations of these adverse structural and 
functional changes to the vasculature and contributes to the incidence of hypertension and 
the development of atherosclerosis 15. Stiffening of the peripheral arteries also leads to 
increases in arterial wall stress 16. The association between vascular stiffening and blood 
pressure is particularly interesting because the functional relationship is likely 
bidirectional. Elevated blood pressure may cause vascular damage and accelerated artery 
stiffening 11. Whether vascular stiffness antedates hypertension or vice versa is unclear.  
 
The clinical spectrum of ASCVD is wide and includes individuals who are asymptomatic 
as well as those with symptoms. Notably various diseases are linked with the progression 
of atherosclerotic obstruction of oxygen-rich blood flow. Vascular events include fatal 
and non-fatal MI, angina pectoris (AP), coronary insufficiency, intermittent claudication 
(peripheral vascular disease), coronary heart disease (CHD), ischaemic cardiomyopathy 
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(IC), peripheral artery disease (PAD), cerebral infarction or ischemic stroke, and 
hemorrhagic stroke, and transient ischemic attack (TIA).  
The importance of prevention 
Despite current medical therapy: vascular bypass operations and endovascular procedures, 
patients with PAD tend to be at higher risk for cardiovascular events compared with 
patients with CAD alone 2 suggested by a three to five fold increase in mortality compared 
with age matched controls. More than $21 billion each year is spent on treating PAD in the 
United States alone 17,18, hospitalization and treatment impose a great financial burden on 
health-care systems with increasing concern 2. Intervention is often necessary and helpful 
but it is common for patients to experience post-operative complications and have recurring 
symptoms which require repeated treatment, there is still an increased need for preventative 
intervention 17.  
Current Treatment Modalities  
The European Society of Cardiology 4 recommends managing atherosclerotic symptoms 
through various treatment modalities including lifestyle modification focusing on 
smoking cessation, daily activity (30min/d), management of BMI (≤25 kg/m2), and diet 
19. Pharmacological treatment is used to achieve blood pressure (BP) control and lipid-
lowering treatment to achieve LDL cholesterol control 20. The American Heart 
Association and American College of Cardiology guidelines recommend a LDL goal of 




A growing body of evidence indicates that nutrient intake may contribute to the 
development and progression of ASCVD 1. ASCVD is a chronic inflammatory condition 
that is associated with longstanding poor nutrition habits, such as eating patterns that are 
low in nutrients with anti-inflammatory and antioxidant properties 2. The promotion of 
healthy dietary21 patterns may reduce oxidative stress, enhance endothelial cell function 
and improve erythrocyte deformability, blood viscosity and oxygen perfusion in 
atherosclerosis-induced muscle ischemia; all of which could lead to improvements in 
clinical outcomes 1. 
 
Consumption of a healthy diet has also been shown to be effective in controlling blood 
pressure (BP) and reducing cardiovascular risks 22. The 2013 American Heart Association 
(AHA) and American College of Cardiology Composite Task Force guidelines (ACC) 
address nutrition-focused risk reduction strategies for cardiovascular disease in a broad 
context, with the aim of improving public health 20. The guidelines endorse a “Heart 
Healthy Lifestyle,” and they provide a general framework for incorporating healthy 
nutrition into lifestyle management to improve blood pressure and lipid control 23. They 
emphasize broad nutrient categories that are associated with better cardiovascular 
outcomes (eg. fruits and vegetables, whole grains, legumes, etc.) 20,24, although an 
important limitation is that particular nutrients that may benefit patients with advanced 
cardiovascular disease are not explicitly identified. The most specific suggestions are 
embedded in recommendations for lowering low-density lipoprotein cholesterol (LDL-C) 
25: the task force advises obtaining a maximum of five-to-six percent of total calories from 
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saturated fat, reducing dietary monounsaturated fats (e.g., oleic acid found in olive oil) 23, 
and minimizing intake of foods rich in trans-fats (found in milk, animal fats and some 
vegetable oils) 2.  
 
Knowledge about specific nutritional deficiencies can help guide therapeutic efforts. 
Achieving a better understanding of diet and CV association may also facilitate the design 
and execution of prospective and randomized trials with clinical outcomes such as major 
adverse cardiovascular events and limb-related endpoints (e.g. claudication distance, limb 
revascularization, and amputation) 26. Furthermore, if physicians and health professionals 
have a better understanding of specific nutrients and their effects on atherosclerotic 
progression, they may be better equipped to give advice about healthful nutrition. The chief 
nutrients that have been negatively associated with atherosclerosis include omega-3 
polyunsaturated fatty acids (n-3 PUFAs), folate and B-series vitamins, and anti-oxidants 
26,27. Additional nutrients, in particular sodium, saturated fats, and fiber, have also been 
strongly linked to atherosclerosis risk 28. 
The Dietary Approaches to Stop Hypertension (DASH) diet 
The Dietary Approaches to Stop Hypertension (DASH) eating pattern, a diet rich in fruits, 
vegetables, whole grains and low-fat dairy with a reduced content of sodium, saturated and 
total fat was introduced as an ideal diet for hypertension treatment 11,21. Although there is 
conflicting evidence on the influence on diastolic BP, most studies have repeatedly 
demonstrated that adherence to the DASH diet is associated with a decrease in systolic BP 
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15,29–32. Furthermore, it seems that the effect of DASH diet on blood pressure occurs largely 
in hypertensive adults15,29–32. The DASH diet may contribute to prevention of some cases 
of heart failure (HF) because it effectively reduces BP and LDL cholesterol in clinical trials 
33,34. This diet focuses on high intakes of fruits, vegetables, low-fat dairy, and whole grains 
resulting in high potassium, magnesium, calcium, and fiber, moderately high protein, and 
low total and saturated fat consumption 1,13,22,35). In multivariable-adjusted analyses, men 
in the highest quartile of the DASH component score had a 22% lower rate of HF events 
then those in the lowest quartile (p for trend = 0.006) 31. In a meta-analysis of 17 
RCT’s DASH diet significantly reduced systolic blood pressure by 6.74 mmHg (95%CI: -
8.25, -5.23, I2 = 78.1%) and diastolic blood pressure by 3.54 mmHg (95%CI: -4.29, -2.79, 
I2 = 56.7%) 33. In the FOS Cohort, SBP increases by 0.34mmHg and DBP by 0.10mmHg 
annually. Every unit increase in the DASH score resulted in lowering SBP of 0.054 
mmHg/year (p = 0.028) 36. Concordance with the DASH diet has been shown to reduce BP 
in short term intervention studies, but the long term impact is unclear 33,35. Folsom and 
colleagues demonstrated that greater adherence with DASH did not have an independent 
long term association with hypertension or cardiovascular mortality among 20,993 women, 
ages 55-69 37. Endorsed AHA guidelines prescribe to patients with or at risk of 




Figure 1. The DASH eating pattern21 
 
Physical Activity and overall Cardiovascular Incidence  
Compared with other preventive strategies, physical activity may be a particularly efficient 
method of reducing the risk of future CVD at the population level because it modifies 
several key risk factors simultaneously and has independent favorable effects on the 
cardiovascular system 38.  Joint guidelines from the American College of Sports Medicine 
and the AHA recommend that otherwise healthy persons aged 18 to 65 years should engage 
in moderate-intensity physical activity for at least 30-40 minutes 5 days per week (180 
minutes per week) or vigorous-intensity activity for at least 20 minutes at least 3 times per 
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week (60 minutes per week) to promote and maintain health 39. The guidelines 
acknowledge that an increase in physical activity beyond the recommendations may be 
associated with additional health benefits, including blood pressure reduction and weight 
loss. From current literature, little is known regarding whether there is an upper limit of 
physical activity at which these benefits may cease 40.  
Both men and women who reported higher levels of physical activity and fitness were 
found to have reductions in relative risk (by about 20%–35%) of death in numerous long-
term studies assessing the relative risk of CVD41). Biological mechanisms may be 
responsible for the reduction in the risk of chronic disease and premature death associated 
with routine physical activity. For instance, routine physical activity has been shown to 
improve body composition (e.g., through reduced abdominal adiposity and improved 
weight control), 39,42 enhance lipoprotein profiles including reduced triglyceride levels, 
increased high-density lipoprotein (HDL) cholesterol levels and lower the ratio of low-
density lipoprotein (LDL) to HDL10,39, improve glucose homeostasis and insulin 
sensitivity, 39 reduce blood pressure, reduce systemic inflammation, decrease blood 
coagulation, improve coronary blood flow, and enhance endothelial function 39. all factors 
that play a major role in CVD 43.  
Chronic inflammation, as indicated by elevated circulating levels of inflammatory 
mediators such as C-reactive protein, has been shown to be strongly associated with most 
of the chronic diseases whose prevention has benefited from exercise. Recent RCTs have 
shown that exercise training may cause marked reductions in C-reactive protein levels.44 
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Each of these factors may explain directly or indirectly the reduced incidence of chronic 
disease and premature death among people who engage in routine physical activity. 
Routine physical activity is also associated with improved psychological well-being (e.g., 
through reductions in stress, anxiety and depression)39,42. Psychological well-being is 
particularly important for the prevention and management of cardiovascular disease, but it 
also has important implications for the prevention and management of other chronic 
diseases such as diabetes, osteoporosis, hypertension, obesity, cancer and depression 45.  
In the Framingham Heart Study third generation cohort, greater physical activity was 
associated with lower vascular stiffness 40. The benefits of regular exercise on vascular 
structure and function are commonly attributed to evident reductions in arterial stiffness 
after a single bout of sub-maximal exercise, and are suggested to provide benefit, including 
a reduction in central blood pressure. While higher levels of cardiorespiratory fitness are 
associated with lower basal (i.e. resting) arterial stiffness in older adults, the influence of 
cardiorespiratory fitness on the post-exercise arterial stiffness response is not well defined. 
Increased arterial stiffness is observed with ageing and in individuals with low 
cardiorespiratory fitness (VO2 peak) and associated with cardiovascular risk. Following 
exercise, transient arterial stiffness reductions offer short-term benefit, but may depend on 
exercise intensity 43.  
 
Data on physical activity in relation to vascular and echocardiographic measures at the 
community level is limited 38, and previous epidemiological studies lack objective 
measures of physical activity. Although several studies have shown that physical activity 
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is associated with improvement in CVD risk factors and subclinical disease measures in 
various populations, some uncertainty remains (Garcia et al., 2019, Brauer, 2011) 
Gaps in evidence  
Solid evidence is still needed in many aspects of the management of atherosclerosis. In 
numerous situations adequate trials are lacking and treatment of atherosclerosis is 
extrapolated from data regarding coronary heart disease. In regards to interventional 
therapy, rapid changes in available therapeutic technique create a difficult situation where 
clinical practice follows the development. Moreover, atherosclerosis may involve 
multiple sites, creating a large number of clinical scenarios that are difficult to investigate 
in a systematic way. These aspects contribute to the broad spectrum of gaps in evidence 
surrounding management. While hypertension is a well-established risk factor for 
cardiovascular disease (CVD) events, uncertainty exists regarding the relative importance 
of various blood pressure (BP) components in predicting risk. Despite increased use of 
protective medications, atherosclerosis was still associated with an elevated risk of CV 
event or death 1. Suggesting that medical therapy alone might not fully attenuate the 
excess risk associated with atherosclerosis. The development and progression of 
atherosclerosis may be modified by giving attention to previously mentioned controllable 




Purpose and Aims 
The role of the DASH dietary pattern, alone and in combination with physical 
activity on the risk of ASCVD is not fully understood 36. The aim of this study is to evaluate 
the independent and combined effects of the DASH dietary pattern and MVPA on ASCVD 




Study Sample  
The Framingham Offspring Study comprises the offspring of the original 
Framingham Study participants or spouses of the offspring. More than 5000 subjects 
were enrolled between 1971–1975. These individuals have been examined nine times 
over the past 40 years, at approximately 4-year intervals. Data related to medical status, 
laboratory blood values, lifestyle factors, physical activity, and diet were collected at 
each exam visit.  
The current study analysis included participants who are >30 years of age and 
provided dietary data at exam visits 3 and 5 (dietary assessment data first available) along 
with activity data at exam visits 4 and 7 (physical activity assessment data available). 
Individuals were followed from the baseline exam for these analyses (exam 3, 1984) to 
the last date of follow-up in 2013 where CVD incidence is available. We excluded 
subjects who had prevalent cancer, type 2 diabetes mellitus (T2DM), prevalent CVD, 
subjects missing dietary data at exams 3 and 5 and those missing physical activity data 

























































Participants Excluded for: 
• Invalid Diet  
• Previous ASCVD event  
• Missing DASH score  
• Missing MVPA score  
• Prevalent Cancer  
• Aged <30 years  
 
 
Total incident cardiovascular 
(CV) event (n= 445) 
Men (n= 268) 
Women (n= 177) 
 
FOS sample at exam 




Atherosclerotic Cardiovascular Event Defined  
In our study, major ASCVD events are defined as the first date of onset of the following 
events: fatal or non-fatal MI, angina pectoris (AP), coronary heart disease death (CHD, 
overall death, ischaemic cardiomyopathy (IC), ischemic cerebral infarction (CI), cerebral 
vascular accident (CVA also known as a stroke), atherothrombotic brain infarction (ABI), 
transient ischemic attack (TIA), cerebral embolism, and hemorrhagic bleeds. 
Assessment of adherence to DASH  
Dietary Assessment 
Diet was assessed at exam cycle 3 (1983-1988) and exam cycle 5 (1991-1995) of the 
FOS by a trained nutritionist. Three-day diet records were collected following 
standardized procedures which measured food intake with use of standard food models to 
aid in estimating food portions. Dietary records were analyzed for nutrient content 
including energy, micronutrients, vitamins, and minerals using the Nutrition Data System 
of the University of Minnesota 47. Adherence to the DASH dietary pattern will be based 
on a previously-defined DASH score protocol 48. 
Creating the DASH score  
The goal of the analysis was to determine the association of adherence to DASH eating 
pattern on incident ASCVD. Scores were based on an estimated mean intake of 2000 
kilocalories per day (kcals) as a standard of energy intake 48. The DASH score is 
comprised of the 10 food components that reflect the DASH diet food groups: (1) total 
grains, (2) whole grains, (3) vegetables (4) fruits, (5) low-fat or fat free milk and milk 
products, (6) all meats, poultry and fish, (7) nuts, seeds and legumes (8) fats and oils, (9) 
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sweets and added sugars and (10) sodium (Table 1). Each food group was assigned a 
score from 0 to 1. One point will be assigned for meeting each guidelines and then all 
points summed to create the total score.  
 
The DASH diet guidelines recommend four to five daily servings of vegetables 36. Thus, 
a full point was assigned to those consuming four or more servings of vegetables daily, 
with a partial point (0.5) given to those with vegetable intake approaching the 
recommended level (2 to 3 servings/d) and no points (0) given to those consuming far 
less than the recommended level (fewer than 2 servings/d). For fruits and whole grains 
where intake was determined to be at or over the dietary guidelines, a full point was also 
issued. Partial points were given to those who were below the standard guidelines. The 
total DASH score is a sum of the scores for each individual food group with a maximum 
score of 10. Reverse scoring was applied for food groups where less intake is 
recommended 48. A full point was assigned to those consuming five or less servings of 
sweets per week, with a partial point (0.5) given to those consuming six to seven servings 
per week, and no points (0) given to those consuming eight or more servings of sweets 
per week (Table 1).  
 
Nutrient intake estimates (percentage of calories from fat and percentage of calories from 
saturated fatty acids) were used to evaluate concordance with the fat-related components 
of the DASH diet because fats and oils are spread across various food groupings making 
this element of the diet difficult to account for in the scoring of individual food 
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groupings. Although the DASH diet emphasizes low-fat dairy and low-fat meats, it is 
difficult to classify individual dairy foods and meats as “low-fat” (e.g. 2% milk could be 
considered either a low-fat or regular-fat dairy food). Estimated sodium intake (in 
milligrams per day) was used a criterion because the DASH diet guidelines include 
quantitative criteria for this nutrient 29 (Table 2). The scoring system was based on the 
premise that each of the major DASH diet guidelines should contribute equally to the 
total index score. The minimum score for each component was 1, with a maximum total 
of 10, which would indicate total concordance with the DASH diet guidelines. A score of 
0 would represent total nonadherence. Sensitivity analyses were used to categorize the 
DASH score into three groups (low, moderate, and high adherence) (i.e., Low adherence: 
DASH score <3.54; Moderate adherence: 3.54-<4.91; High adherence: ≥4.91). Finally 
the DASH scores were dichotomized (low, high) as follows: (Low DASH <4.45; High 
















































DASH guideline index item Score 
Total Grains   
≥7 servings/d 1 
5-6 servings/d 0.5 
<5 servings/d 0 
Whole Grains  
≥ 2 servings/d 1 
1 serving/d 0.5 
< 1 serving/d 0 
Vegetables   
≥ 4 servings/d 1 
2-3 servings/d 0.5 
< 2 servings/d 0 
Fruits   
≥ 4 servings/d 1 
2-3 servings/d 0.5 
< 2 servings/d 0 
Fat-free or low-fat dairy products   
≥ 2 servings/d 1 
1 serving/d 0.5 
< 1 serving/d 0 
Lean meats, poultry, and fish   
≥ 4 servings/d 1 
3 servings/d 0.5 
< 2 servings/d 0 
Nuts, seeds, and legumes   
≥ 4 servings/d 1 
2-3 servings/d 0.5 
< 2 servings/d 0 
Fats and oils   
2-3 servings/d 1 
1 serving/d 0.5 
< 1 serving/d 0 
Sweets and added sugars   
≤ 5 servings/wk 1 
6-7 servings/wk 0.5 
≥ 8 servings/wk 0 
Sodium   
≤ 1500 mg/d 1 
1501-2400 mg/d 0.5 






Table 2. Foods commonly consumed in the U.S. according to the DASH eating pattern food components. Adopted from NHLBI 
Food Group Serving Sizes Examples and Notes 
Significance of Each Food 
Group to the DASH Eating 
Plan 
Grains and Whole grains 
1 slice bread Whole-wheat bread and rolls, whole-wheat 
pasta, English muffin, pita bread, bagel, 
cereals, grits, oatmeal, brown rice, unsalted 
pretzels and popcorn 
Major sources of energy and fiber 
1 oz dry cereal 
½ cup cooked rice, pasta, or cereal 
Vegetables 
1 cup raw leafy vegetable 
Broccoli, carrots, collards, green beans, green 
peas, kale, lima beans, potatoes, spinach, 
squash, sweet potatoes, tomatoes 
Rich sources of potassium, 
magnesium, and fiber 
½ cup cut-up raw or cooked 
vegetable 
½ cup vegetable juice 
Fruits 
1 medium fruit  Apples, apricots, bananas, dates, grapes, 
oranges, grapefruit, grapefruit juice, 
mangoes, melons, peaches, pineapples, 
raisins, strawberries, tangerines 
Important sources of potassium, 
magnesium, and fiber 
¼ cup dried fruit 
½ cup fresh, frozen, or canned fruit 
½ cup fruit juice 
Fat-free or low-fat dairy 
products 
1 cup milk or yogurt Fat-free milk or buttermilk; fat-free, low-fat, 
or reduced-fat cheese; fat-free/low-fat regular 
or frozen yogurt 
Major sources of calcium and 
protein 1½ oz cheese 
Lean meats, poultry, and 
fish 
1 oz cooked meats, poultry, or fish Select only lean; trim away visible fats; broil, 
roast, or poach; remove skin from poultry 
Rich sources of protein and 
magnesium 
1 egg 
Nuts, seeds, and legumes 
⅓ cup or 1½ oz nuts 
Almonds, filberts, mixed nuts, peanuts, 
walnuts, sunflower seeds, peanut butter, 
kidney beans, lentils, split peas 
Rich sources of energy, 
magnesium, protein, and fiber 
2 Tbsp peanut butter 
2 Tbsp or ½ oz seeds 
½ cup cooked legumes (dried 
beans, peas) 
Fats and oils 
1 tsp soft margarine 
Soft margarine, vegetable oil (canola, corn, 
olive, safflower), low-fat mayonnaise, light 
salad dressing 
The DASH study had 27% of 
calories as fat, including fat in or 
added to foods 
1 tsp vegetable oil 
1 Tbsp mayonnaise 
2 Tbsp salad dressing 
Sweets and added sugars 
1 Tbsp sugar 
Fruit-flavored gelatin, fruit punch, hard 
candy, jelly, maple syrup, sorbet and ices, 
sugar 
Sweets should be low in fat 
1 Tbsp jelly or jam 
½ cup sorbet, gelatin dessert 
1 cup lemonade 
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Assessment of adherence to Physical Activity 
PA was assessed at exam cycles 4 and 7 in the Framingham Offspring cohort 49. The  
MVPA score was a composite score constructed for each participant by multiplying a 
weight for each hour in their typical day in activities of different intensity levels (based 
on oxygen consumption or metabolic equivalents) and summing up these weighted hours 
over a 24-hour period 50. Participants were asked to report the number of hours in a 
typical day spent sleeping (weighting factor [WF] = 1) and in sedentary (WF = 1.1), light 
(WF = 1.5), moderate (WF = 2.4), and heavy activities (WF = 5) (Tan et al., 2017, 
Kannel 1986). Moderate activity is defined as housework, climbing stairs, or light sports 
such as bowling or golf 38. Heavy activity is defined as more vigorous household work 
such as yard work or intensive exercise (jogging, swimming) 38. For the final models, 
only the hours spent in moderate or vigorous (heavy) activities were summed to crease a 
MVPA score expressed in metabolic equivalents per day using data from exam 4. For 
those missing activity data at exam 4, data from exam 7 was used. MVPA score was 
classified into quintiles (Q1: 1.2-6.0; Q2: 6.1-9.6; Q3: 9.7-13.3; Q4: 13.4-18.3; Q5: 18.4-
54.6) and then dichotomized into low and high (Lower MVPA <6.1; Higher MVPA 
>6.1). 
 Covariates  
Potential Confounders  
The potential confounders explored in this analysis include age, sex, BMI, waist-
to-hip ratio, education level, smoking (cigarettes per day), alcohol intake (grams per day), 
use of lipid lowering medication, use of antihypertension medication, total energy intake, 
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percent energy from carbohydrates, fat, and protein. Only those factors that confounded 
the estimates by 10% or more were included in the final models: age, sex, BMI, cigarettes 
per day, and grams per day of alcohol consumed. 
Statistical Analysis 
Statistical analyses were conducted using SAS statistical software (version 9.4; 
SAS Institute, Cary, NC). The DASH and MVPA scores was roughly normally distributed 
but for these analyses were generally categorized for analysis. The outcome was incident 
total atherosclerotic cardiovascular events. Incidence rates for each outcome were 
computed in each category of the DASH score and separately for each quintile of MVPA 
scores. Person-years of follow-up time were calculated in each category from the baseline 
dietary assessment exam to the first of the following events: occurrence of first 
atherosclerotic event, loss to follow-up, date of last exam, or date of death. ASCVD 
incidence rate was computed by dividing the number of ASCVD cases by the total number 
of person-years in each category of the DASH score and MVPA quintile. Cox-proportional 
hazards regression models were used to estimate adjusted HRs (and 95% CIs) for the 
occurrence of first atherosclerotic CVD event using those with lowest scores as the referent 
group.  
All models were adjusted for age, sex (except sex-specific models), cigarettes per 
day, alcohol, and BMI. We examined a predefined list of potential confounders and 
evaluated the extent to which they altered the age and sex adjusted-parameter estimates by 
approximately 10% or more, including: body mass index (kg/m2, continuous), physical 
activity (hours/day, continuous) for the DASH models, height, pack-years of smoking, 
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antihypertensive medication use, lipid-lowering drugs, and waist-to-hip ratio (cm, 
continuous), Factors, such as educational level, antihypertensive medication, and lipid 
lowering medication, that were not confounders of the relationship between DASH or 




The mean value for DASH scores at exam 3 and 5 of the FOS was 4.21 (± 0.84) (range 
0.81-6.85) with a median value of 4.24 out of a maximum possible score of 10. Figure 3 
shows the approximately normal distribution of these scores with substantial clustering of 
the scores around the median.  
 
Table 3 shows the baseline subject characteristics according to DASH scores classified as 
low, moderate, or high. Participants in the highest category of DASH score, compared to 
those in the lowest category were older, more likely to be female, had a lower BMI, and 
had higher HDL cholesterol. Those in the highest tertile smoked less and consumed less 
alcohol compared with the lowest DASH tertile. Participants in the lowest tertile of 
DASH score had a higher waist-to-hip ratio, higher total cholesterol, higher fasting 
triglycerides, and fasting glucose. There were no important trends in diastolic or systolic 
blood pressures or lipid levels, with the exception of an inverse association with 
triglyceride levels, across categories of the DASH score. Similarly, there were no 
meaningful differences in the patterns of use of antihypertensive or lipid-lowering 
medications associated with the DASH score. 
 
Table 4 demonstrates the similarity in total energy intake in the lowest and highest DASH 
score categories, with the middle category having the lowest total energy consumption.  
Participants with the highest DASH scores consumed the largest amount of carbohydrates 
and had the lowest energy-adjusted fat intakes. Protein intake did not differ across 
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categories of the DASH score. The total MVPA scores declined across categories of the 
DASH score. 
 
Figure 5 shows the distribution of the baseline MVPA scores, with a mean MVPA score 
of 12.59 (± 7.95), (range 2.4- 54.6). While roughly normally distributed, there is some 



































Figure 3: The distribution of the DASH Dietary pattern score in the 3rd and 5th examination 
of the Framingham Offspring Cohort (N= 2503). Mean (± standard deviation): 4.21 (± 
0.84); median (min, max): 4.25 (0.81,6.85); 5th, 25th, 75th and 95th percentiles: 2.76, 3.68, 


















































Figure 4: The distribution of the Moderate Vigorous Physical Activity Score (MVPA) 
pattern score in the 4th examination of the Framingham Offspring Cohort (N=2503). Mean 
(± standard deviation): 12.59 (± 7.95); median (min, max): 11.0 (2.4, 54.6); 5th, 25th, 75th 





















Table 3. Baseline characteristics (mean (±SD), or (column percentage) according to 
categories of DASH score: Framingham Offspring Cohort   
 DASH Categories   
  Low Moderate High p -value 
Characteristics (n=2503) n=499 n=1500 n=504  
Age (years) 49.1 (±9.8) 50.3 (±9.9) 50.5 (±10.0) <0.04 
Sex    <0.0001 
   Female (54.6) 219 850 297 
 
   Male (45.4) 280 650 207  
Smoking (cigs/day) 9.20 (±14.2) 4.27 (±10.1) 3.0 (±9.0) <.0001 
Alcohol consumption (g/day) 21.6 (±23.6) 9.23 (±13.1) 8.23 (±14.8) <.0001 
BMI (kg)/ (m²) 26.4 (± 4.4) 26.2 (± 4.5) 25.7 (± 3.9) <.0145  
Waist-to-Hip 0.89 (± 0.1) 0.86 (± 0.1) 0.86 (± 0.1) <.0001 
DBP (mmHg) 77.2 (±9.1) 77.7 (±9.5) 77.7 (±9.5) < 0.51 
SBP (mmHg) 123.1 (±16.1) 123.5 (±16.7) 123.2 (±16.7) < 0.86  
Total cholesterol (mg/dL) 211.1 (±40) 209.3 (±39.2) 207.7 (±38.0) < 0.40 
HDL cholesterol (mg/dL) 51.2 (±14.7) 51.7 (±14.9) 52.6 (±14.3) < 0.30 
LDL cholesterol (mg/dL) 135.3 (±36.4) 134.2 (±35.6) 133.0 (±34.5) < 0.60 
Triglycerides 126.0 (±92.0) 120.1 (±85.9) 110.9 (±78.9) <0.02 
Fasting Glucose 93.2 (±9.4) 91.8 (±9.70) 92.0 (±9.3) < 0.02 
Hypertensive medication n (%) 
(n=328) 
70 (14.0) 187 (12.5) 71 (14.1) <.0001 
Lipid lowering medication n (%) 
(n=38) 
5 (1.0) 27 (1.8) 6 (1.2) <0.36 
DASH categories: Low: 0.81-<3.54; Moderate: 3.54-<4.91 High: ≥4.91. P values were generated from 
analysis of variance for continuous and chi-square for categorical variables. Abbreviations:  DASH, Dietary 





















Table 4: Baseline macronutrient intakes and physical activity (mean (±SD), or (column 
percentage) according to categories of DASH score: Framingham Offspring Cohort   
  DASH Categories    
  Low Moderate High p -value 
Characteristics (n=2503) n=499 n=1500 n=504  
Total energy (kcals/day) 1965 (±622) 1880 (±547) 1960 (±487) <.0012 
Carbohydrates (% kcals) 40.5 (±8.3) 46.5 (±7.2) 50.6 (±7.1) <.0001 
Protein (% kcals) 17.1 (±4.2) 16.8 (±3.2) 16.8 (±2.8) <0.20 
Total fat (% kcals) 36.4 (±6.6) 35.6 (±6.3) 32.7 (±6.7) <.0001 
Activity Measures 
    
   Total MVPA hrs/day 13.1 (±8.5) 12.7 (±8.0) 11.9 (±6.9) <0.04 
   Sedentary time, hrs/day 6.0 (±2.9) 6.1 (±2.9) 6.3 (±2.9) <0.16 
 DASH categories: Low: 0.81-<3.54; Moderate: 3.54-<4.91 High: ≥4.91. P values were generated from 
analysis of variance for continuous and chi-square for categorical variables. Abbreviations:  DASH, Dietary 
approaches to stop hypertension dietary pattern; MVPA, Moderate-vigorous physical activity; Kcals, 
Kilocalories (calories). 
Total Atherosclerotic Cardiovascular Disease  
Event Risk and DASH 
  
Of the 2503 men and women aged 30-82 years with dietary data from exams 3 
and 5 of the FOS, 445 experienced an ASCVD event (Table 5). Overall, those in the 
moderate DASH score category had the lowest CVD incident rate 8.03 per 1000 person-
years of follow-up compared with 9.33 and 8.79 CV events per 1000 person years in the 
low and high DASH score categories, respectively. After adjusting for age, sex, BMI, 
alcohol (grams/day), and cigarettes (cig/day) at the baseline exam, men and women in the 
moderate DASH score category had a non-statistically significant 8% lower risk of a CV 
event compared with the lowest adherence to the DASH group, (HRtertile2: 0.92 (0.72-
1.12); HRtertile3: 1.07 (0.79-1.45)). Overall, the DASH score was not associated with 
CVD. However, analyses stratifying by sex revealed that higher adherence to DASH 
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score among women was associated with a lower total CVD event risk but again the 
confidence intervals around these estimates were wide. 
Event risk and moderate-vigorous physical activity  
Of the 2503 men and women at exam 4 and 7 of the FOS, those in the highest 
MVPA score quintile category had the lowest CV event incident rate 7.84 per 1000 
person-years of follow-up compared with 9.39 CV events per 1000 person years in the 
lowest MVPA score quintile categories, respectively (Table 6). After adjusting for age, 
sex, BMI, alcohol (grams/day), and cigarettes (cigs/day) at baseline exam, men and 
women in the highest of quintile of MVPA had a 26% lower risk of CV event compared 




























DASH categories: Low: 0.81-<3.54; Moderate: 3.54-<4.91 High: ≥4.91. Abbreviations:  DASH, Dietary Approaches to Stop 
Hypertension eating pattern; PY, Person-years; HR, hazard ratio;  CI, confidence interval; Ref, reference category; # Number.  
a The analysis was adjusted for age, sex, body mass index, alcohol, cigarettes (per day) (for all subjects model). The analysis was 
adjusted for age, BMI, alcohol, cigarettes (per/day) (for sex-specific models). 
Table 5: Risk of ASCVD event, associated with Tertiles of DASH score 
 #Subjects PY #cases Rate/1000py HR CI (95%)
a 
Overall (n= 2503)      
DASH Categories 
     
Low 499 9972.88 93 9.33 1 (Ref) 
Moderate 1500 31883.88 256 8.03 0.92 (0.72-1.19) 
High  504 10915.48 96 8.79 1.07 (0.79-1.45) 
Men (n=1137)      
DASH Categories      
Low 280 5405.28 62 11.47 1 (Ref) 
Moderate 650 13299.85 146 10.98 0.93 (0.68-1.27) 
High  207 4113.97 60 14.58 1.31 (0.90-1.90) 
Women (n=1366)      
DASH Categories      
Low 219 4567.6 31 6.79 1 (Ref) 
Moderate 850 18584.03 110 5.92 0.94 (0.61-1.44) 






MVPA scores for overall: Q1: 1.20-6.0; Q2: 6.10-9.60; Q3: 9.70-13.30; Q4: 13.40-18.30; Q5: 18.40-54.60, MVPA scores for men:  
Q1: 1.20-6.0; Q2: 6.10-9.60; Q3: 9.70-13.30; Q4: 13.40-18.30; Q5: 18.40-54.60, MVPA scores for women: Q1: 1.20-6.00; Q2: 6.10-9.60; Q3: 9.70-
13.30; Q4: 13.40-18.30; Q5: 18.40-41.20, Abbreviations: MVPA, Moderate vigorous physical activity; PY, Person-years; HR, hazard ratio;  CI, 
confidence interval; Q, Quintile; Ref, reference category; # Number. a The analysis was adjusted for  age, sex , body mass index, alcohol, cigarettes 
(per day) for all subjects model.  This analysis was adjusted for  age, BMI, alcohol,  cigarettes (per/day) (for sex specific models)
 
 
Table 6: Risk of ASCVD event, associated with Quintiles of MVPA score. 
 #Subjects PY #cases Rate/1000py HR CI (95%)
a 
Overall (n= 2503)      
MVPA Quintiles      
Q1 526 11078.05 104 9.39 1 (Ref) 
Q2 485 10258.88 85 8.29 0.88 (0.66-1.18) 
Q3 502 10833.39 85 7.85 0.84 (0.63-1.12) 
Q4 484 10271.64 90 8.76 0.88 (0.66-1.16) 
Q5 506 10330.28 81 7.84 0.74 (0.55-0.99) 
Men (n= 1137)      
MVPA Quintiles      
Q1  219 4254.56 59 13.87 1 (Ref) 
Q2  213 4314.14 51 11.82 0.94 (0.64-1.37) 
Q3  213 4421.42 46 10.40 0.76 (0.52-1.12) 
Q4 224 4555.24 54 11.85 0.80 (0.55-1.16) 
Q5 268 5273.74 58 11.00 0.74 (0.51-1.06) 
Women (n= 1366)      
MVPA Quintiles      
Q1  307 6823.49 45 6.59 1 (Ref) 
Q2  272 5944.74 34 5.72 0.77 (0.49-1.21) 
Q3  289 6411.97 39 6.08 0.97 (0.63-1.49) 
Q4 260 5716.4 36 6.30 1.00 (0.64-1.55) 




Combined adherence of DASH and Physical Activity on event risk  
Cross classification of DASH and MVPA yielded four exposure groups (1) Low 
DASH/Low MVPA (control group); (2) High DASH/Low MVPA (effect of DASH 
alone), (3) Low DASH/High MVPA (effect of activity alone), and (4) High DASH/High 
MVPA (synergistic effect of diet and activity). Those in the category with the highest 
DASH score and highest MVPA score had the lowest CV event incident rate 6.90 per 
1000 person-years of follow-up compared with 9.0 CV events per 1000 person years in 
the low DASH/low MVPA score categories (Table 7). After adjusting for age, sex, BMI, 
alcohol (grams/day), and cigarettes (cigs/day) at baseline exam, men and women in the 
highest adherence category of DASH and MVPA score had a 22% lower risk of CVD 
compared individuals in the reference DASH/MVPA score category 
(HRHighDASH/HighMVPA): 0.78 (0.57-1.07)). Analysis stratifying by sex revealed that higher 
adherence to diet and physical activity had a larger impact on total CV event risk in 
women compared to men. In particular, women with greatest adherence to the combined 
effect of diet and physical activity had a 43% (95% CI: 0.36-0.90) lower CVD risk 






DASH and MVPA scores for overall: Cutoff Points: Low DASH <4.45; High DASH >4.45; Low MVPA <6.1; High MVPA >6.1 
Abbreviations: DASH, Dietary Approaches to Stop Hypertension; MVPA, Moderate vigorous physical activity; PY, Person-years; HR, 
hazard ratio; CI, confidence interval; Ref, reference category; # Number.  
a The analysis was adjusted for age, sex, body mass index, alcohol, cigarettes (per day) (for all subjects model). The analysis was 




Table 7: Risk of ASCVD event, associated with Categories of DASH and MVPA score. 
 #Subjects PY #cases Rate/1000py HR CI (95%)
a 
Overall (n= 2503)      
Diet and Activity Category      
Low DASH, Low MVPA 316 6583.58 59 8.9617 1 (Ref) 
High DASH, Low MVPA 210 4494.47 45 10.0123 1.13 (0.76-1.68) 
Low DASH, High MVPA 1186 24310.58 221 9.0907 0.94 (0.70-1.26) 
High DASH, High MVPA 791 17383.61 120 6.9031 0.78 (0.57-1.07) 
Men (n= 1137)      
Diet and Activity Category      
Low DASH, Low MVPA 128 2497.73 27 10.8098 1 (Ref) 
High DASH, Low MVPA 91 1756.83 32 18.2146 1.63 (0.97-2.74) 
Low DASH, High MVPA 603 12006.13 136 11.3275 1.02 (0.67-1.54) 
High DASH, High MVPA 315 6558.41 73 11.1307 1.01 (0.64-1.58) 
Women (n= 1366)      
Diet and Activity Category      
Low DASH, Low MVPA 188 4085.85 32 7.83191 1 (Ref) 
High DASH, Low MVPA 119 2737.64 13 4.74862 0.65 (0.34-1.25) 
Low DASH, High MVPA 583 12304.45 85 6.90807 0.89 (0.56-1.34) 




The primary goal of this study was to examine the relationships between the Dietary 
Approaches to Stop Hypertension eating pattern, physical activity, and the development 
of incident cardiovascular disease (CVD). We found that the DASH score alone was not 
associated with CVD risk. However, analyses stratifying by sex revealed that higher 
adherence to DASH score among women was associated with a lower total CVD event 
risk but the confidence intervals around these estimates were wide. However, MVPA was 
inversely associated with CVD risk in this cohort. We then evaluated the independent and 
combined effects of DASH and MVPA scores on cardiovascular event risk and found 
that among women, those with higher adherence to a DASH score and higher levels of 
MVPA had the lowest risks of CVD. While men and women together in the highest 
adherence category of DASH and MVPA had a lower risk of CVD compared with 
individuals in the reference group (low DASH/low MVPA score), there was no 
association between a DASH eating pattern and CVD risk in men alone. 
 
Most studies of DASH have focused on BP outcomes rather than long-term CVD risk. 
While most randomized trials of short duration have shown that DASH diet reduces BP 
in those with elevated levels, a few (e.g., the PREMIER trial) find little benefit beyond 
other lifestyle interventions48,51. However, those studies had lower levels of concordance 
a DASH pattern and higher levels of concordance may be necessary to achieve the 




Our findings are not consistent with those of a previous prospective cohort study of 
women living in Iowa. In that study, Folsom followed 20,993 women from 1986-2002 
and found that greater concordance with DASH guidelines did not have an independent 
long-term association with hypertension or CV mortality48.  
 
In the FOS cohort, adults in the highest of quintile of MVPA had more than 25% lower 
risks of CV events. In a RCT of 51 adults stratified into fitness tertiles based on VO2, 
Perissiou found that arterial stiffness response following exercise is dependent on both 
the intensity of the exercise and the level of cardiorespiratory fitness in healthy older 
adult males43. Moderate intensity and high intensity exercise led to a positive attenuation 
of pulse wave velocity compared to seated controls43. 
 
An important strength of the current study includes its large sample size and long-term 
follow up (20 years). Confounding effects may be minimized as a result of careful 
systematic collection of potential confounding variables and carefully adjusted CV event 
outcomes. Finally, these results are strengthened by the use of dietary records to collect 
dietary information. Thus, the intake of DASH-related foods (e.g., dairy, fruits, 
vegetables, nuts, legumes) were derived from all sources including mixed dishes.  
 
There are several limitations in this study as well. CVD is a heterogeneous disease rather 
than a single disease, and risk factors may not be the same for all CVD subtypes31. The 
current DASH and MVPA scores are based on a self-reporting; since the component 
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scores are standardized to energy intake and since energy intake is subject to biased 
reporting with all self-report measures, this is likely to be an important source of error. 
Some degree of misclassification of physical activity score is also possible since activity 
may vary substantially over time for some individuals and may not be fully representative 
of activity levels during the time period at risk. Since physical activity responses were 
based on recall and no source of verification was available to confirm accuracy, 
misclassification is also possible. Further, the MVPA score cannot distinguish the 
beneficial effects of leisure activity from those of work related activities50.  
 
In the future, we plan to evaluate individual subtypes of ASCVD such as PAD and other 
measures of vascular function. The ankle–brachial index (ABI) is the ratio of systolic 
blood pressure at the ankle to that in the arm 4. This measure is available in the FOS  and 
may be used to distinguish a decreased arterial pressure owing to obstructive arterial 
disease from general hypotension related to other conditions 52. In addition to peripheral 
artery disease, the ABI also is an indicator of generalized atherosclerosis because lower 
levels have been associated with higher rates of concomitant coronary and 
cerebrovascular disease, and with the presence of cardiovascular risk factors. In 
population cohort studies in the United States and Europe, a low ABI has been related to 
an increased incidence of mortality (total and cardiovascular), myocardial infarction, and 
stroke 50-53. These increased relative risks have been shown to be independent of baseline 
cardiovascular disease and risk factors, suggesting that the ABI might have an 
independent role in predicting cardiovascular events. Overall, the ABI provides good 
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sensitivity (80%) and excellent specificity (95%) to detect PAD and generalized 
atherosclerosis 53.  
 
This prospective cohort study showed that consumption of a DASH eating pattern may be 
one effective dietary strategy for protecting against cardiovascular event risk, especially 
among women. The beneficial effects in women were particularly evident among those 
whose dietary adherence to a DASH pattern was accompanied by higher levels of 
moderate and vigorous activity. Future studies are needed to evaluate whether closer 
adherence to the DASH eating pattern in men would be of greater benefit in the 














LIST OF JOURNAL ABBREVIATIONS 
BMJ      British Medical Journal 
Curr Opin Cell Biol    Current Opinion in Cell Biology 
Eur Heart J     European Heart Journal 
FASEB J     FASEB Journal 
FEBS Lett     FEBS Letters 
JAMA JAMA: The Journal of the American 
Medical Association 
J Am Pharm Assoc Journal of the American Pharmacists 
Association 
Mol Cell Biol     Molecular and Cellular Biology 
Nat Rev Cardiol    Nature Reviews.  Cardiology 






1. Grenon, S., Vittinghoff, E., Owens, C., Conte, M., Whooley, M., & Cohen,B. 
Peripheral artery disease and risk of cardiovascular events in patients with 
coronary artery disease: Insights from the Heart and Soul Study. Vascular 
Medicine., 2013; 18(4), 176-184. doi: 10.1177/1358863X13493825 
2. Nosova, E., Conte, M., & Grenon, S. (n.d.). Advancing beyond the "heart-healthy 
diet" for peripheral arterial disease. Journal of Vascular Surgery., 2015; 61(1), 
265-274. doi: 10.1016/j.jvs.2014.10.022 
3. Fowkes, F Gerry R, Aboyans, Victor, Fowkes, Freya J I, McDermott, Mary M, 
Sampson, Uchechukwu K A, & Criqui, Michael H. (2017). Peripheral artery 
disease: Epidemiology and global perspectives. Nature Reviews 
Cardiology., 2017; 14(3), 156-170. doi: 10.1038/nrcardio.2016.179 
4. Tendera, M. et al. ESC Guidelines on the diagnosis and treatment of peripheral 
artery diseases. European. Heart Journal. 32, 2851–2906 (2011). 
5. Tabas, I., & Glass, C. Anti-inflammatory therapy in chronic disease: Challenges 
and opportunities. Science. 2013;339(6116), 166-172. doi: 
10.1126/science.1230720 
6. Criqui, M., & Aboyans, V. Epidemiology of peripheral artery disease. Circulation 
Research : Journal of the American Heart Association.2015; 116(9), 1509-1526. 
doi:10.1161/CIRCRESAHA.116.303849 
7. Fowkes, F., Housley, E., Riemersma, R., Macintyre, C., Cawood, E., Prescott, R., 
& Ruckln.d.). Smoking, lipids, glucose intolerance, and blood pressure as risk 
factors for peripheral atherosclerosis compared with ischemic heart disease in the 
Edinburgh Artery Study. American Journal of Epidemiology 2016; 135(4), 331-
340. 10.1093/oxfordjournals.aje.a116294 
8. Rafieian-Kopaei, M., Setorki, M., Doudi, M., Baradaran, A., & Nasri, H. 
Atherosclerosis: Process, indicators, risk factors and new hopes. International 
Journal of Preventive Medicine., 2014; 5(8), 927-946. issn: 2008-7802 , 2008-
8213 






10. Bergheanu, S., Bodde, M., & Jukema, J. Pathophysiology and treatment of 
atherosclerosis : Current view and future perspective on lipoprotein modification 
treatment. Netherlands Heart Journal : Monthly Journal of the Netherlands 
Society of Cardiology and the Netherlands Heart Foundation. 2017; 25(4), 231-
242. doi: 10.1007/s12471-017-0959-2 
11. Kyaw, T., Peter, K., Li, Y., Tipping, P., Toh, B., & Bobik, A. Cytotoxic 
lymphocytes and atherosclerosis: Significance, mechanisms and therapeutic 
challenges. British Journal of Pharmacology. 2017; 174(22), 3956-3972. doi: 
10.1111/bph.13845 
12. Li, F., Tian, F., Wang, L., Williamson, I., Sharifi, B., & Shah, P. Pleiotrophin 
(PTN) is expressed in vascularized human atherosclerotic plaques: 
IFN{gamma}/JAK/STAT1 signaling is critical for the expression of PTN 
inmacrophages. The FASEB Journal. 2010; 24(3), 810-822. doi: 10.1096/fj.09-
140780 
13. Ben-Shlomo, Y., Spears, M., Boustred, C., May, M., Anderson, S., Benjamin, E., 
Vasan, R. Aortic pulse wave velocity improves cardiovascular event prediction: 
An individual participant meta-analysis of prospective observational data from 
17,635 subjects. Journal of the American College of Cardiology. 2014; 63(7), 636-
646. doi: 10.1016/j.jacc.2013.09.063 
14. Tesauro, M., Mauriello, A., Rovella, V., Annicchiarico-Petruzzelli, C., Cardillo, 
G., Melino, N., & Di Daniele. Arterial ageing: From endothelial dysfunction to 
vascular calcification. Journal of Internal Medicine. 2017; 281(5), 471-482. doi: 
10.1111/joim.12605 
15. Niiranen, T., Kalesan, B., Larson, M., Hamburg, N., Benjamin, E., Mitchell, G., & 
Vasan, R. Aortic-Brachial Arterial Stiffness Gradient and Cardiovascular Risk in 
the Community: The Framingham Heart Study. Hypertension. 2017; 69(6), 1022-
1028. doi: 10.1161/HYPERTENSIONAHA.116.08917 
16. Vasan, RS., Short, MI. Interrelations Between Arterial Stiffness, Target Organ 
Damage, and Cardiovascular Disease Outcomes. Journal of the American Heart 
Association. 2019; 8(14). issn: 2047-9980 
17. Flu, H., Van der Hage, J., Knippenberg, B., Merkus, J., Hamming, J., & 
Lardenoye, J. (n.d.). Treatment for peripheral arterial obstructive disease: An 
appraisal ofthe economic outcome of complications. Journal of Vascular Surgery. 





18. Mahoney, E., Wang, K., Cohen, D., Hirsch, A., Alberts, M., Eagle, K., . . . Bhatt, 
D. One-year costs in patients with a history of or at risk for atherothrombosis in the 
United States. Circulation. 2008; 1(1), 38-45. 
doi: 10.1161/CIRCOUTCOMES.108.775247 
19. Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., 
Scholte op Reimer, W. European guidelines on cardiovascular disease prevention 
in clinical practice: Executive summary: Fourth Joint Task Force of the European 
Society of Cardiology and Other Societies on Cardiovascular Disease Prevention 
in Clinical Practice (Constituted by representatives of nine societies and by 
invited experts). European Heart Journal. 2007; 28(19), 2375-2414. doi: 
10.1093/eurheartj/ehm316 
 
 20. Hirsch, Alan T, Haskal, Ziv J, Hertzer, Norman R, Bakal, Curtis W, Creager, Mark 
A, Halperin, Jonathan L, Anderson, Jeffrey L. ACC/AHA 2005 guidelines for the 
management of patients with peripheral arterial disease (lower extremity, renal, 
mesenteric, and abdominal aortic): Executive summary a collaborative report from 
the American Association for Vascular Surgery/Society for Vascular Surgery, 
Society for Cardiovascular Angiography and Interventions, Society for Vascular 
Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA 
Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for 
the Management of Patients With Peripheral Arterial Disease) endorsed by the 
American Association of Cardiovascular and Pulmonary Rehabilitation; National 
Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic 
Inter-Society Consensus; and Vascular Disease Foundation. Journal of the 
American College of Cardiology. 2006; 47(6), 1239-1312. 
doi: 10.1016/j.jacc.2005.10.009 
21. Jones, N., Forouhi, N., Khaw, K., Wareham, N., & Monsivais, P. Accordance to 
the Dietary Approaches to Stop Hypertension diet pattern and cardiovascular 
disease in aBritish, population-based cohort. European Journal of Epidemiology. 
2018; 33(2), 235-244. doi: 10.1007/s10654-017-0354-8 
22. Franklin, S., Lopez, V., Wong, N., Mitchell, G., Larson, M., Vasan, R., & Levy, D. 
Single versus combined blood pressure components and risk for cardiovascular 
disease: The Framingham Heart Study. Circulation : Journal of the American 
Heart Association. 2009; 119(2), 243-250. doi: 
10.1161/CIRCULATIONAHA.108.797936 
23. Eckel, R. H. et al. Reprint: 2013 AHA/ACC Guideline on Lifestyle Management 
to Reduce Cardiovascular Risk. Journal of the American Pharmacist. Association. 




24. Hemler, E. C. & Hu, F. B. Plant-Based Diets for Cardiovascular Disease 
Prevention: All Plant Foods Are Not Created Equal. Current Atherosclerosis 
Reports. 2019; Vol.21(5). issn: 1523-3804 
25. Hashemi, R., Mehdizadeh Khalifani, A., Rahimlou, M. & Manafi, M. Comparison 
of the effect of Dietary Approaches to Stop Hypertension diet and American 
Diabetes Association nutrition guidelines on lipid profiles in patients with type 2 
diabetes: A comparative clinical trial. Nutrition. Diet. 2019. doi:10.1111/1747-
0080.12543 
26. Brostow, D., Hirsch, A., Collins, T., & Kurzer, M. The role of nutrition and body 
composition in peripheral arterial disease. Nature Reviews 
Cardiology.2012; 9(11), 634-643. doi: 10.1038/nrcardio.2012.117 
27. Bhupathiraju, S., & Tucker, K. Coronary heart disease prevention: Nutrients, 
foods, and dietary patterns. Clinica Chimica Acta. 2018; 412(17-18), 1493-1514. 
doi: 10.1016/j.cca.2011.04.038 
28. Gao, S., Fitzpatrick, A., Psaty, B., Jiang, R., Post, W., Cutler, J., & Maciejewski, 
M. Suboptimal nutritional intake for hypertension control in 4 ethnic 
groups. Archives of Internal Medicine. 2009; 169(7), 702-707. 
doi: 10.1001/archinternmed.2009.17 
29. Buendia, J. R., Bradlee, M. L., Daniels, S. R., Singer, M. R. & Moore, L. L. 
Longitudinal effects of dietary sodium and potassium on blood pressure in 
adolescent girls. JAMA Pediatrics. 2015; 560–568. 
doi: 10.1001/jamapediatrics.2015.0411 
30. Kaess, B., Rong, J., Larson, M., Hamburg, N., Vita, J., Levy, D., Mitchell, G. 
Aortic stiffness, blood pressure progression, and incident hypertension. JAMA : 
The Journal of the American Medical Association. 2012; 308(9), 875-881. 
doi: 10.1001/2012.jama.10503 
31. Levitan, E., Wolk, A., & Mittleman, M. Relation of consistency with the dietary 
approaches to stop hypertension diet and incidence of heart failure in men aged 45 
to 79 years. The American Journal of Cardiology. 2009; 104(10), 1416-1420. 
doi: 10.1016/j.amjcard.2009.06.061 
32. Shim, C. (n.d.). Arterial-cardiac interaction: The concept and implications. J 






33. Saneei, P., Salehi-Abargouei, A., Esmaillzadeh, L., & Azadbakht. Influence of 
Dietary Approaches to Stop Hypertension (DASH) diet on blood pressure: A 
systematicreview and meta-analysis on randomized controlled trials. Nutrition, 
Metabolism, and Cardiovascular Diseases. 2014; NMCD. 24(12), 1253-1261. 
doi: 10.1016/j.numecd.2014.06.008 
34. Lin, H., Baghdasarian, S., Singer, M., Mott, M., Bradlee, M., Pickering, R., & 
Moore, L. Dietary Cholesterol, Lipid Levels, and Cardiovascular Risk among 
Adults with Diabetes or Impaired Fasting Glucose in the Framingham 
OffspringStudy. Nutrients., 10(6), Nutrients. 2018; Vol.10(6). 
doi: 10.3390/nu10060770 
35. Jiang, J., Liu, M., Troy, L., Bangalore, S., Hayes, R., & Parekh, N. Concordance 
with DASH diet and blood pressure change: Results from the Framingham 
Offspring Study (1991-2008). Journal of Hypertension. 2015; 33(11), 2223-2230. 
doi: 10.1097/HJH.0000000000000710 
36. Folsom, A., Parker, E., & Harnack, L. Degree of concordance with DASH diet 
guidelines and incidence of hypertension and fatal cardiovascular 
disease. American Journal of Hypertension. 2007; 20(3), 225-232. 
doi: 10.1016/j.amjhyper.2006.09.003 
37. Andersson, C. et al. Physical activity measured by accelerometry and its 
associations with cardiac structure and vascular function in young and middle-
agedadults. Journal of the American Heart Association. 2015; Vol.4(3). issn: 2047-
9980 
38. Warburton, D., Nicol, C., & Bredin, S. (n.d.). Health benefits of physical activity: 
The evidence. Canadian Medical Association Journal. 2006; 174(6), 801-809. 
doi: 10.1503/cmaj.051351 
39. Sesso, H., Paffenbarger, R., & Lee, I. Physical activity and coronary heart disease 
in men: The Harvard Alumni Health Study. Circulation. 2000;  Journal of the 
AmericanHeart Association., 102(9), 975-980.  doi: 10.1161/01.cir.102.9.975 
40. Macera, C., Hootman, J., & Sniezek, J. Major public health benefits of physical 
activity. Arthritis & Rheumatism.2003;49(1), 122-128. doi: 10.1002/art.10907 
41. Seidell, J., Cigolini, M., Deslypere, J., Charzewska, J., Ellsinger, B., & Cruz, A. 
Body fat distribution in relation to physical activity and smoking habits in 38-year-
old European men. The European Fat Distribution Study. American Journal of 




42. Perissiou, M., Bailey, T., Windsor, M., Nam, M., Greaves, K., Leicht, A., Askew, 
C. Effects of exercise intensity and cardiorespiratory fitness on the acuteresponse 
of arterial stiffness to exercise in older adults. European Journal of 
AppliedPhysiology. 2018; 118(8), 1673-1688. doi: 10.1007/s00421-018-3900-5 
43. Nicklas, B., You, T., & Pahor, M. Behavioural treatments for chronic systemic 
inflammation: Effects of dietary weight loss and exercise training. Canadian 
Medical Association Journal. 2005; 172(9), 1199-1209. 
doi: 10.1503/cmaj.1040769 
44. McGavock, J. et al. Cardiovascular adaptations to exercise training in 
postmenopausal women with type 2 diabetes mellitus. Cardiovascular 
Diabetology. 2004; vol 3.issn: 1475-2840 
45. Garcia, J. M. et al. Types of Sedentary Behavior and Risk of Cardiovascular 
Events and Mortality in Blacks: The Jackson Heart Study. (n.d.). Journal of the 
American Heart Association. 2019; 8(13). issn: 2047-9980 
46. Lin, H., Baghdasarian, S., Singer, M., Mott, M., Bradlee, M., Pickering, R., & Mo 
(n.d.). Dietary Cholesterol, Lipid Levels, and Cardiovascular Risk among Adults 
with Diabetes or Impaired Fasting Glucose in the Framingham Offspring Study. 
Nutrients. 2018; Vol.10(6). doi: 10.3390/nu10060770 
47. Tan, Z., Spartano, N., Beiser, A., DeCarli, C., Auerbach, S., Vasan, R., & 
Seshadri, S. Physical Activity, Brain Volume, and Dementia Risk: The 
FraminghamStudy. The Journals of Gerontology. 2017; 72(6), 789-795. 
doi: 10.1093/gerona/glw130 
48. Kiely, D., Wolf, P., Cupples, L., Beiser, A., & Kannel, W. Physical activity and 
stroke risk: The Framingham Study. American Journal of Epidemiology.1994; 
140(7), 608-620. DOI: 10.1093/oxfordjournals.aje.a117298 
49. Appel, L., Champagne, C., Harsha, D., Cooper, L., Obarzanek, E., Elmer, P., 
Young, D. Effects of comprehensive lifestyle modification on blood pressure 
control: Main results of the PREMIER clinical trial. JAMA : The Journal of the 
AmericanMedical Association. 2003; 289(16), 2083-2093. doi: 
10.1001/jama.289.16.2083 
50. Fowkes, F. G. R. et al. Ankle brachial index combined with Framingham Risk 
Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2012. 
doi:10.1001/jama.300.2.197 
51. Weatherley, B. D. et al. The association of the ankle-brachial index with incident 
coronary heart disease: The Atherosclerosis Risk In Communities (ARIC) study, 
1987-2001. BMC Cardiovascular Disorders. 2007; Vol.7. issn: 1471-2261 
 
 45 
52. Newman, A., Siscovick, D., Manolio, T., Polak, J., Fried, L., Borhani, N., & 
Wolfson, S. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular 
HealthStudy. Cardiovascular Heart Study (CHS) Collaborative Research 
Group. Circulation :Journal of the American Heart Association.1993; 88(3), 837-
845. doi; 10.1161/01.cir.88.3.837 
53. Aboyans, V., Criqui, M., Abraham, P., Allison, M., Creager, M., Diehm, C., . . . 
Treat-Jacobson, D. Measurement and interpretation of the ankle-brachial index: 
Ascientific statement from the American Heart Association. Circulation : Journal 
of theAmerican Heart Association.2012; 126(24), 2890-2909. 
doi: 10.1161/CIR.0b013e31827
 
 46 
CURICULUM VITAE 
 
 
 47 
 
 
 
 
 48 
 
 
 
 
 
 
 
 49 
 
 50 
 
 51 
 
 
 
 
 
 
 
 
 52 
 
 
 
 53 
 
 
 
 
 
 
 
 54 
